Global Transthyretin Stabilizer Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.
LPI (LP Information)' newest research report, the “Transthyretin Stabilizer Industry Forecast” looks at past sales and reviews total world Transthyretin Stabilizer sales in 2022, providing a comprehensive analysis by region and market sector of projected Transthyretin Stabilizer sales for 2023 through 2029. With Transthyretin Stabilizer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transthyretin Stabilizer industry.
This Insight Report provides a comprehensive analysis of the global Transthyretin Stabilizer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transthyretin Stabilizer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Transthyretin Stabilizer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transthyretin Stabilizer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transthyretin Stabilizer.
The global Transthyretin Stabilizer market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Transthyretin Stabilizer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Transthyretin Stabilizer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Transthyretin Stabilizer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Transthyretin Stabilizer players cover Pfizer Inc., Merck & Co., AstraZeneca Plc., GlaxoSmithKline Plc., Corino Therapeutics Inc., Alnylam Pharmaceuticals, Bellus Health Inc., Ionis Pharmaceuticals, Inc. and Proclara Bioscience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Transthyretin Stabilizer market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Transthyretin Stabilizer market?
What factors are driving Transthyretin Stabilizer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transthyretin Stabilizer market opportunities vary by end market size?
How does Transthyretin Stabilizer break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Transthyretin found in serum and cerebrospinal fluid of body is one of the transport protein carrying thyroxine and retinol-binding proteins. Transthyretin destabilization can take place due to inherited mutations or ageing.Transthyretin stabilizers prevent destabilization of protein and amyloidosis progression.
LPI (LP Information)' newest research report, the “Transthyretin Stabilizer Industry Forecast” looks at past sales and reviews total world Transthyretin Stabilizer sales in 2022, providing a comprehensive analysis by region and market sector of projected Transthyretin Stabilizer sales for 2023 through 2029. With Transthyretin Stabilizer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transthyretin Stabilizer industry.
This Insight Report provides a comprehensive analysis of the global Transthyretin Stabilizer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transthyretin Stabilizer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Transthyretin Stabilizer market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transthyretin Stabilizer and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transthyretin Stabilizer.
The global Transthyretin Stabilizer market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Transthyretin Stabilizer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Transthyretin Stabilizer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Transthyretin Stabilizer is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Transthyretin Stabilizer players cover Pfizer Inc., Merck & Co., AstraZeneca Plc., GlaxoSmithKline Plc., Corino Therapeutics Inc., Alnylam Pharmaceuticals, Bellus Health Inc., Ionis Pharmaceuticals, Inc. and Proclara Bioscience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Transthyretin Stabilizer market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Diflunisal
- Tafamidis
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Merck & Co.
- AstraZeneca Plc.
- GlaxoSmithKline Plc.
- Corino Therapeutics Inc.
- Alnylam Pharmaceuticals
- Bellus Health Inc.
- Ionis Pharmaceuticals, Inc.
- Proclara Bioscience
- Arturus Therapeutics
- Prothena Corporation Plc.
What is the 10-year outlook for the global Transthyretin Stabilizer market?
What factors are driving Transthyretin Stabilizer market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Transthyretin Stabilizer market opportunities vary by end market size?
How does Transthyretin Stabilizer break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transthyretin Stabilizer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Transthyretin Stabilizer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Transthyretin Stabilizer by Country/Region, 2018, 2022 & 2029
2.2 Transthyretin Stabilizer Segment by Type
2.2.1 Diflunisal
2.2.2 Tafamidis
2.2.3 Others
2.3 Transthyretin Stabilizer Sales by Type
2.3.1 Global Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
2.3.2 Global Transthyretin Stabilizer Revenue and Market Share by Type (2018-2023)
2.3.3 Global Transthyretin Stabilizer Sale Price by Type (2018-2023)
2.4 Transthyretin Stabilizer Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Online Pharmacies
2.4.5 Others
2.5 Transthyretin Stabilizer Sales by Application
2.5.1 Global Transthyretin Stabilizer Sale Market Share by Application (2018-2023)
2.5.2 Global Transthyretin Stabilizer Revenue and Market Share by Application (2018-2023)
2.5.3 Global Transthyretin Stabilizer Sale Price by Application (2018-2023)
3 GLOBAL TRANSTHYRETIN STABILIZER BY COMPANY
3.1 Global Transthyretin Stabilizer Breakdown Data by Company
3.1.1 Global Transthyretin Stabilizer Annual Sales by Company (2018-2023)
3.1.2 Global Transthyretin Stabilizer Sales Market Share by Company (2018-2023)
3.2 Global Transthyretin Stabilizer Annual Revenue by Company (2018-2023)
3.2.1 Global Transthyretin Stabilizer Revenue by Company (2018-2023)
3.2.2 Global Transthyretin Stabilizer Revenue Market Share by Company (2018-2023)
3.3 Global Transthyretin Stabilizer Sale Price by Company
3.4 Key Manufacturers Transthyretin Stabilizer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transthyretin Stabilizer Product Location Distribution
3.4.2 Players Transthyretin Stabilizer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TRANSTHYRETIN STABILIZER BY GEOGRAPHIC REGION
4.1 World Historic Transthyretin Stabilizer Market Size by Geographic Region (2018-2023)
4.1.1 Global Transthyretin Stabilizer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Transthyretin Stabilizer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Transthyretin Stabilizer Market Size by Country/Region (2018-2023)
4.2.1 Global Transthyretin Stabilizer Annual Sales by Country/Region (2018-2023)
4.2.2 Global Transthyretin Stabilizer Annual Revenue by Country/Region (2018-2023)
4.3 Americas Transthyretin Stabilizer Sales Growth
4.4 APAC Transthyretin Stabilizer Sales Growth
4.5 Europe Transthyretin Stabilizer Sales Growth
4.6 Middle East & Africa Transthyretin Stabilizer Sales Growth
5 AMERICAS
5.1 Americas Transthyretin Stabilizer Sales by Country
5.1.1 Americas Transthyretin Stabilizer Sales by Country (2018-2023)
5.1.2 Americas Transthyretin Stabilizer Revenue by Country (2018-2023)
5.2 Americas Transthyretin Stabilizer Sales by Type
5.3 Americas Transthyretin Stabilizer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin Stabilizer Sales by Region
6.1.1 APAC Transthyretin Stabilizer Sales by Region (2018-2023)
6.1.2 APAC Transthyretin Stabilizer Revenue by Region (2018-2023)
6.2 APAC Transthyretin Stabilizer Sales by Type
6.3 APAC Transthyretin Stabilizer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Transthyretin Stabilizer by Country
7.1.1 Europe Transthyretin Stabilizer Sales by Country (2018-2023)
7.1.2 Europe Transthyretin Stabilizer Revenue by Country (2018-2023)
7.2 Europe Transthyretin Stabilizer Sales by Type
7.3 Europe Transthyretin Stabilizer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transthyretin Stabilizer by Country
8.1.1 Middle East & Africa Transthyretin Stabilizer Sales by Country (2018-2023)
8.1.2 Middle East & Africa Transthyretin Stabilizer Revenue by Country (2018-2023)
8.2 Middle East & Africa Transthyretin Stabilizer Sales by Type
8.3 Middle East & Africa Transthyretin Stabilizer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transthyretin Stabilizer
10.3 Manufacturing Process Analysis of Transthyretin Stabilizer
10.4 Industry Chain Structure of Transthyretin Stabilizer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transthyretin Stabilizer Distributors
11.3 Transthyretin Stabilizer Customer
12 WORLD FORECAST REVIEW FOR TRANSTHYRETIN STABILIZER BY GEOGRAPHIC REGION
12.1 Global Transthyretin Stabilizer Market Size Forecast by Region
12.1.1 Global Transthyretin Stabilizer Forecast by Region (2024-2029)
12.1.2 Global Transthyretin Stabilizer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transthyretin Stabilizer Forecast by Type
12.7 Global Transthyretin Stabilizer Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.1.3 Pfizer Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Merck & Co.
13.2.1 Merck & Co. Company Information
13.2.2 Merck & Co. Transthyretin Stabilizer Product Portfolios and Specifications
13.2.3 Merck & Co. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co. Main Business Overview
13.2.5 Merck & Co. Latest Developments
13.3 AstraZeneca Plc.
13.3.1 AstraZeneca Plc. Company Information
13.3.2 AstraZeneca Plc. Transthyretin Stabilizer Product Portfolios and Specifications
13.3.3 AstraZeneca Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AstraZeneca Plc. Main Business Overview
13.3.5 AstraZeneca Plc. Latest Developments
13.4 GlaxoSmithKline Plc.
13.4.1 GlaxoSmithKline Plc. Company Information
13.4.2 GlaxoSmithKline Plc. Transthyretin Stabilizer Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GlaxoSmithKline Plc. Main Business Overview
13.4.5 GlaxoSmithKline Plc. Latest Developments
13.5 Corino Therapeutics Inc.
13.5.1 Corino Therapeutics Inc. Company Information
13.5.2 Corino Therapeutics Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Corino Therapeutics Inc. Main Business Overview
13.5.5 Corino Therapeutics Inc. Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Transthyretin Stabilizer Product Portfolios and Specifications
13.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Bellus Health Inc.
13.7.1 Bellus Health Inc. Company Information
13.7.2 Bellus Health Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.7.3 Bellus Health Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bellus Health Inc. Main Business Overview
13.7.5 Bellus Health Inc. Latest Developments
13.8 Ionis Pharmaceuticals, Inc.
13.8.1 Ionis Pharmaceuticals, Inc. Company Information
13.8.2 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.8.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.9 Proclara Bioscience
13.9.1 Proclara Bioscience Company Information
13.9.2 Proclara Bioscience Transthyretin Stabilizer Product Portfolios and Specifications
13.9.3 Proclara Bioscience Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Proclara Bioscience Main Business Overview
13.9.5 Proclara Bioscience Latest Developments
13.10 Arturus Therapeutics
13.10.1 Arturus Therapeutics Company Information
13.10.2 Arturus Therapeutics Transthyretin Stabilizer Product Portfolios and Specifications
13.10.3 Arturus Therapeutics Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Arturus Therapeutics Main Business Overview
13.10.5 Arturus Therapeutics Latest Developments
13.11 Prothena Corporation Plc.
13.11.1 Prothena Corporation Plc. Company Information
13.11.2 Prothena Corporation Plc. Transthyretin Stabilizer Product Portfolios and Specifications
13.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Prothena Corporation Plc. Main Business Overview
13.11.5 Prothena Corporation Plc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Transthyretin Stabilizer Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Transthyretin Stabilizer by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Transthyretin Stabilizer by Country/Region, 2018, 2022 & 2029
2.2 Transthyretin Stabilizer Segment by Type
2.2.1 Diflunisal
2.2.2 Tafamidis
2.2.3 Others
2.3 Transthyretin Stabilizer Sales by Type
2.3.1 Global Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
2.3.2 Global Transthyretin Stabilizer Revenue and Market Share by Type (2018-2023)
2.3.3 Global Transthyretin Stabilizer Sale Price by Type (2018-2023)
2.4 Transthyretin Stabilizer Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Online Pharmacies
2.4.5 Others
2.5 Transthyretin Stabilizer Sales by Application
2.5.1 Global Transthyretin Stabilizer Sale Market Share by Application (2018-2023)
2.5.2 Global Transthyretin Stabilizer Revenue and Market Share by Application (2018-2023)
2.5.3 Global Transthyretin Stabilizer Sale Price by Application (2018-2023)
3 GLOBAL TRANSTHYRETIN STABILIZER BY COMPANY
3.1 Global Transthyretin Stabilizer Breakdown Data by Company
3.1.1 Global Transthyretin Stabilizer Annual Sales by Company (2018-2023)
3.1.2 Global Transthyretin Stabilizer Sales Market Share by Company (2018-2023)
3.2 Global Transthyretin Stabilizer Annual Revenue by Company (2018-2023)
3.2.1 Global Transthyretin Stabilizer Revenue by Company (2018-2023)
3.2.2 Global Transthyretin Stabilizer Revenue Market Share by Company (2018-2023)
3.3 Global Transthyretin Stabilizer Sale Price by Company
3.4 Key Manufacturers Transthyretin Stabilizer Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transthyretin Stabilizer Product Location Distribution
3.4.2 Players Transthyretin Stabilizer Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TRANSTHYRETIN STABILIZER BY GEOGRAPHIC REGION
4.1 World Historic Transthyretin Stabilizer Market Size by Geographic Region (2018-2023)
4.1.1 Global Transthyretin Stabilizer Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Transthyretin Stabilizer Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Transthyretin Stabilizer Market Size by Country/Region (2018-2023)
4.2.1 Global Transthyretin Stabilizer Annual Sales by Country/Region (2018-2023)
4.2.2 Global Transthyretin Stabilizer Annual Revenue by Country/Region (2018-2023)
4.3 Americas Transthyretin Stabilizer Sales Growth
4.4 APAC Transthyretin Stabilizer Sales Growth
4.5 Europe Transthyretin Stabilizer Sales Growth
4.6 Middle East & Africa Transthyretin Stabilizer Sales Growth
5 AMERICAS
5.1 Americas Transthyretin Stabilizer Sales by Country
5.1.1 Americas Transthyretin Stabilizer Sales by Country (2018-2023)
5.1.2 Americas Transthyretin Stabilizer Revenue by Country (2018-2023)
5.2 Americas Transthyretin Stabilizer Sales by Type
5.3 Americas Transthyretin Stabilizer Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transthyretin Stabilizer Sales by Region
6.1.1 APAC Transthyretin Stabilizer Sales by Region (2018-2023)
6.1.2 APAC Transthyretin Stabilizer Revenue by Region (2018-2023)
6.2 APAC Transthyretin Stabilizer Sales by Type
6.3 APAC Transthyretin Stabilizer Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Transthyretin Stabilizer by Country
7.1.1 Europe Transthyretin Stabilizer Sales by Country (2018-2023)
7.1.2 Europe Transthyretin Stabilizer Revenue by Country (2018-2023)
7.2 Europe Transthyretin Stabilizer Sales by Type
7.3 Europe Transthyretin Stabilizer Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Transthyretin Stabilizer by Country
8.1.1 Middle East & Africa Transthyretin Stabilizer Sales by Country (2018-2023)
8.1.2 Middle East & Africa Transthyretin Stabilizer Revenue by Country (2018-2023)
8.2 Middle East & Africa Transthyretin Stabilizer Sales by Type
8.3 Middle East & Africa Transthyretin Stabilizer Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transthyretin Stabilizer
10.3 Manufacturing Process Analysis of Transthyretin Stabilizer
10.4 Industry Chain Structure of Transthyretin Stabilizer
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transthyretin Stabilizer Distributors
11.3 Transthyretin Stabilizer Customer
12 WORLD FORECAST REVIEW FOR TRANSTHYRETIN STABILIZER BY GEOGRAPHIC REGION
12.1 Global Transthyretin Stabilizer Market Size Forecast by Region
12.1.1 Global Transthyretin Stabilizer Forecast by Region (2024-2029)
12.1.2 Global Transthyretin Stabilizer Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transthyretin Stabilizer Forecast by Type
12.7 Global Transthyretin Stabilizer Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.1.3 Pfizer Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Merck & Co.
13.2.1 Merck & Co. Company Information
13.2.2 Merck & Co. Transthyretin Stabilizer Product Portfolios and Specifications
13.2.3 Merck & Co. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co. Main Business Overview
13.2.5 Merck & Co. Latest Developments
13.3 AstraZeneca Plc.
13.3.1 AstraZeneca Plc. Company Information
13.3.2 AstraZeneca Plc. Transthyretin Stabilizer Product Portfolios and Specifications
13.3.3 AstraZeneca Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 AstraZeneca Plc. Main Business Overview
13.3.5 AstraZeneca Plc. Latest Developments
13.4 GlaxoSmithKline Plc.
13.4.1 GlaxoSmithKline Plc. Company Information
13.4.2 GlaxoSmithKline Plc. Transthyretin Stabilizer Product Portfolios and Specifications
13.4.3 GlaxoSmithKline Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GlaxoSmithKline Plc. Main Business Overview
13.4.5 GlaxoSmithKline Plc. Latest Developments
13.5 Corino Therapeutics Inc.
13.5.1 Corino Therapeutics Inc. Company Information
13.5.2 Corino Therapeutics Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.5.3 Corino Therapeutics Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Corino Therapeutics Inc. Main Business Overview
13.5.5 Corino Therapeutics Inc. Latest Developments
13.6 Alnylam Pharmaceuticals
13.6.1 Alnylam Pharmaceuticals Company Information
13.6.2 Alnylam Pharmaceuticals Transthyretin Stabilizer Product Portfolios and Specifications
13.6.3 Alnylam Pharmaceuticals Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Alnylam Pharmaceuticals Main Business Overview
13.6.5 Alnylam Pharmaceuticals Latest Developments
13.7 Bellus Health Inc.
13.7.1 Bellus Health Inc. Company Information
13.7.2 Bellus Health Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.7.3 Bellus Health Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bellus Health Inc. Main Business Overview
13.7.5 Bellus Health Inc. Latest Developments
13.8 Ionis Pharmaceuticals, Inc.
13.8.1 Ionis Pharmaceuticals, Inc. Company Information
13.8.2 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Portfolios and Specifications
13.8.3 Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Ionis Pharmaceuticals, Inc. Main Business Overview
13.8.5 Ionis Pharmaceuticals, Inc. Latest Developments
13.9 Proclara Bioscience
13.9.1 Proclara Bioscience Company Information
13.9.2 Proclara Bioscience Transthyretin Stabilizer Product Portfolios and Specifications
13.9.3 Proclara Bioscience Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Proclara Bioscience Main Business Overview
13.9.5 Proclara Bioscience Latest Developments
13.10 Arturus Therapeutics
13.10.1 Arturus Therapeutics Company Information
13.10.2 Arturus Therapeutics Transthyretin Stabilizer Product Portfolios and Specifications
13.10.3 Arturus Therapeutics Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Arturus Therapeutics Main Business Overview
13.10.5 Arturus Therapeutics Latest Developments
13.11 Prothena Corporation Plc.
13.11.1 Prothena Corporation Plc. Company Information
13.11.2 Prothena Corporation Plc. Transthyretin Stabilizer Product Portfolios and Specifications
13.11.3 Prothena Corporation Plc. Transthyretin Stabilizer Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Prothena Corporation Plc. Main Business Overview
13.11.5 Prothena Corporation Plc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Transthyretin Stabilizer Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Transthyretin Stabilizer Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Diflunisal
Table 4. Major Players of Tafamidis
Table 5. Major Players of Others
Table 6. Global Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 7. Global Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Table 8. Global Transthyretin Stabilizer Revenue by Type (2018-2023) & ($ million)
Table 9. Global Transthyretin Stabilizer Revenue Market Share by Type (2018-2023)
Table 10. Global Transthyretin Stabilizer Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 12. Global Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Table 13. Global Transthyretin Stabilizer Revenue by Application (2018-2023)
Table 14. Global Transthyretin Stabilizer Revenue Market Share by Application (2018-2023)
Table 15. Global Transthyretin Stabilizer Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Transthyretin Stabilizer Sales by Company (2018-2023) & (K Units)
Table 17. Global Transthyretin Stabilizer Sales Market Share by Company (2018-2023)
Table 18. Global Transthyretin Stabilizer Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Transthyretin Stabilizer Revenue Market Share by Company (2018-2023)
Table 20. Global Transthyretin Stabilizer Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Transthyretin Stabilizer Producing Area Distribution and Sales Area
Table 22. Players Transthyretin Stabilizer Products Offered
Table 23. Transthyretin Stabilizer Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Transthyretin Stabilizer Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Transthyretin Stabilizer Sales Market Share Geographic Region (2018-2023)
Table 28. Global Transthyretin Stabilizer Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Transthyretin Stabilizer Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Transthyretin Stabilizer Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Transthyretin Stabilizer Sales Market Share by Country/Region (2018-2023)
Table 32. Global Transthyretin Stabilizer Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Transthyretin Stabilizer Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Transthyretin Stabilizer Sales by Country (2018-2023) & (K Units)
Table 35. Americas Transthyretin Stabilizer Sales Market Share by Country (2018-2023)
Table 36. Americas Transthyretin Stabilizer Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Transthyretin Stabilizer Revenue Market Share by Country (2018-2023)
Table 38. Americas Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 39. Americas Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 40. APAC Transthyretin Stabilizer Sales by Region (2018-2023) & (K Units)
Table 41. APAC Transthyretin Stabilizer Sales Market Share by Region (2018-2023)
Table 42. APAC Transthyretin Stabilizer Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Transthyretin Stabilizer Revenue Market Share by Region (2018-2023)
Table 44. APAC Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 45. APAC Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 46. Europe Transthyretin Stabilizer Sales by Country (2018-2023) & (K Units)
Table 47. Europe Transthyretin Stabilizer Sales Market Share by Country (2018-2023)
Table 48. Europe Transthyretin Stabilizer Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Transthyretin Stabilizer Revenue Market Share by Country (2018-2023)
Table 50. Europe Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 51. Europe Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Transthyretin Stabilizer Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Transthyretin Stabilizer Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Transthyretin Stabilizer
Table 59. Key Market Challenges & Risks of Transthyretin Stabilizer
Table 60. Key Industry Trends of Transthyretin Stabilizer
Table 61. Transthyretin Stabilizer Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Transthyretin Stabilizer Distributors List
Table 64. Transthyretin Stabilizer Customer List
Table 65. Global Transthyretin Stabilizer Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Transthyretin Stabilizer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Transthyretin Stabilizer Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Transthyretin Stabilizer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Transthyretin Stabilizer Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Transthyretin Stabilizer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Transthyretin Stabilizer Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Transthyretin Stabilizer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Transthyretin Stabilizer Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Transthyretin Stabilizer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Transthyretin Stabilizer Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Transthyretin Stabilizer Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Transthyretin Stabilizer Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Transthyretin Stabilizer Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 81. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Inc. Main Business
Table 83. Pfizer Inc. Latest Developments
Table 84. Merck & Co. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck & Co. Transthyretin Stabilizer Product Portfolios and Specifications
Table 86. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Merck & Co. Main Business
Table 88. Merck & Co. Latest Developments
Table 89. AstraZeneca Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 90. AstraZeneca Plc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 91. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. AstraZeneca Plc. Main Business
Table 93. AstraZeneca Plc. Latest Developments
Table 94. GlaxoSmithKline Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Plc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 96. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. GlaxoSmithKline Plc. Main Business
Table 98. GlaxoSmithKline Plc. Latest Developments
Table 99. Corino Therapeutics Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 100. Corino Therapeutics Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 101. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Corino Therapeutics Inc. Main Business
Table 103. Corino Therapeutics Inc. Latest Developments
Table 104. Alnylam Pharmaceuticals Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 105. Alnylam Pharmaceuticals Transthyretin Stabilizer Product Portfolios and Specifications
Table 106. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Alnylam Pharmaceuticals Main Business
Table 108. Alnylam Pharmaceuticals Latest Developments
Table 109. Bellus Health Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 110. Bellus Health Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 111. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bellus Health Inc. Main Business
Table 113. Bellus Health Inc. Latest Developments
Table 114. Ionis Pharmaceuticals, Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 115. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 116. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Ionis Pharmaceuticals, Inc. Main Business
Table 118. Ionis Pharmaceuticals, Inc. Latest Developments
Table 119. Proclara Bioscience Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 120. Proclara Bioscience Transthyretin Stabilizer Product Portfolios and Specifications
Table 121. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Proclara Bioscience Main Business
Table 123. Proclara Bioscience Latest Developments
Table 124. Arturus Therapeutics Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 125. Arturus Therapeutics Transthyretin Stabilizer Product Portfolios and Specifications
Table 126. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Arturus Therapeutics Main Business
Table 128. Arturus Therapeutics Latest Developments
Table 129. Prothena Corporation Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 130. Prothena Corporation Plc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 131. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Prothena Corporation Plc. Main Business
Table 133. Prothena Corporation Plc. Latest Developments
Table 1. Transthyretin Stabilizer Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Transthyretin Stabilizer Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Diflunisal
Table 4. Major Players of Tafamidis
Table 5. Major Players of Others
Table 6. Global Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 7. Global Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Table 8. Global Transthyretin Stabilizer Revenue by Type (2018-2023) & ($ million)
Table 9. Global Transthyretin Stabilizer Revenue Market Share by Type (2018-2023)
Table 10. Global Transthyretin Stabilizer Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 12. Global Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Table 13. Global Transthyretin Stabilizer Revenue by Application (2018-2023)
Table 14. Global Transthyretin Stabilizer Revenue Market Share by Application (2018-2023)
Table 15. Global Transthyretin Stabilizer Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Transthyretin Stabilizer Sales by Company (2018-2023) & (K Units)
Table 17. Global Transthyretin Stabilizer Sales Market Share by Company (2018-2023)
Table 18. Global Transthyretin Stabilizer Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Transthyretin Stabilizer Revenue Market Share by Company (2018-2023)
Table 20. Global Transthyretin Stabilizer Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Transthyretin Stabilizer Producing Area Distribution and Sales Area
Table 22. Players Transthyretin Stabilizer Products Offered
Table 23. Transthyretin Stabilizer Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Transthyretin Stabilizer Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Transthyretin Stabilizer Sales Market Share Geographic Region (2018-2023)
Table 28. Global Transthyretin Stabilizer Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Transthyretin Stabilizer Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Transthyretin Stabilizer Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Transthyretin Stabilizer Sales Market Share by Country/Region (2018-2023)
Table 32. Global Transthyretin Stabilizer Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Transthyretin Stabilizer Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Transthyretin Stabilizer Sales by Country (2018-2023) & (K Units)
Table 35. Americas Transthyretin Stabilizer Sales Market Share by Country (2018-2023)
Table 36. Americas Transthyretin Stabilizer Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Transthyretin Stabilizer Revenue Market Share by Country (2018-2023)
Table 38. Americas Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 39. Americas Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 40. APAC Transthyretin Stabilizer Sales by Region (2018-2023) & (K Units)
Table 41. APAC Transthyretin Stabilizer Sales Market Share by Region (2018-2023)
Table 42. APAC Transthyretin Stabilizer Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Transthyretin Stabilizer Revenue Market Share by Region (2018-2023)
Table 44. APAC Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 45. APAC Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 46. Europe Transthyretin Stabilizer Sales by Country (2018-2023) & (K Units)
Table 47. Europe Transthyretin Stabilizer Sales Market Share by Country (2018-2023)
Table 48. Europe Transthyretin Stabilizer Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Transthyretin Stabilizer Revenue Market Share by Country (2018-2023)
Table 50. Europe Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 51. Europe Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Transthyretin Stabilizer Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Transthyretin Stabilizer Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Transthyretin Stabilizer Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Transthyretin Stabilizer Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Transthyretin Stabilizer
Table 59. Key Market Challenges & Risks of Transthyretin Stabilizer
Table 60. Key Industry Trends of Transthyretin Stabilizer
Table 61. Transthyretin Stabilizer Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Transthyretin Stabilizer Distributors List
Table 64. Transthyretin Stabilizer Customer List
Table 65. Global Transthyretin Stabilizer Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Transthyretin Stabilizer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Transthyretin Stabilizer Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Transthyretin Stabilizer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Transthyretin Stabilizer Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Transthyretin Stabilizer Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Transthyretin Stabilizer Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Transthyretin Stabilizer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Transthyretin Stabilizer Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Transthyretin Stabilizer Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Transthyretin Stabilizer Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Transthyretin Stabilizer Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Transthyretin Stabilizer Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Transthyretin Stabilizer Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 81. Pfizer Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Inc. Main Business
Table 83. Pfizer Inc. Latest Developments
Table 84. Merck & Co. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck & Co. Transthyretin Stabilizer Product Portfolios and Specifications
Table 86. Merck & Co. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Merck & Co. Main Business
Table 88. Merck & Co. Latest Developments
Table 89. AstraZeneca Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 90. AstraZeneca Plc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 91. AstraZeneca Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. AstraZeneca Plc. Main Business
Table 93. AstraZeneca Plc. Latest Developments
Table 94. GlaxoSmithKline Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 95. GlaxoSmithKline Plc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 96. GlaxoSmithKline Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. GlaxoSmithKline Plc. Main Business
Table 98. GlaxoSmithKline Plc. Latest Developments
Table 99. Corino Therapeutics Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 100. Corino Therapeutics Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 101. Corino Therapeutics Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Corino Therapeutics Inc. Main Business
Table 103. Corino Therapeutics Inc. Latest Developments
Table 104. Alnylam Pharmaceuticals Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 105. Alnylam Pharmaceuticals Transthyretin Stabilizer Product Portfolios and Specifications
Table 106. Alnylam Pharmaceuticals Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Alnylam Pharmaceuticals Main Business
Table 108. Alnylam Pharmaceuticals Latest Developments
Table 109. Bellus Health Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 110. Bellus Health Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 111. Bellus Health Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bellus Health Inc. Main Business
Table 113. Bellus Health Inc. Latest Developments
Table 114. Ionis Pharmaceuticals, Inc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 115. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 116. Ionis Pharmaceuticals, Inc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Ionis Pharmaceuticals, Inc. Main Business
Table 118. Ionis Pharmaceuticals, Inc. Latest Developments
Table 119. Proclara Bioscience Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 120. Proclara Bioscience Transthyretin Stabilizer Product Portfolios and Specifications
Table 121. Proclara Bioscience Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Proclara Bioscience Main Business
Table 123. Proclara Bioscience Latest Developments
Table 124. Arturus Therapeutics Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 125. Arturus Therapeutics Transthyretin Stabilizer Product Portfolios and Specifications
Table 126. Arturus Therapeutics Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Arturus Therapeutics Main Business
Table 128. Arturus Therapeutics Latest Developments
Table 129. Prothena Corporation Plc. Basic Information, Transthyretin Stabilizer Manufacturing Base, Sales Area and Its Competitors
Table 130. Prothena Corporation Plc. Transthyretin Stabilizer Product Portfolios and Specifications
Table 131. Prothena Corporation Plc. Transthyretin Stabilizer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Prothena Corporation Plc. Main Business
Table 133. Prothena Corporation Plc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Transthyretin Stabilizer
Figure 2. Transthyretin Stabilizer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transthyretin Stabilizer Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Transthyretin Stabilizer Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Transthyretin Stabilizer Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Diflunisal
Figure 10. Product Picture of Tafamidis
Figure 11. Product Picture of Others
Figure 12. Global Transthyretin Stabilizer Sales Market Share by Type in 2022
Figure 13. Global Transthyretin Stabilizer Revenue Market Share by Type (2018-2023)
Figure 14. Transthyretin Stabilizer Consumed in Hospital Pharmacies
Figure 15. Global Transthyretin Stabilizer Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 16. Transthyretin Stabilizer Consumed in Retail Pharmacies
Figure 17. Global Transthyretin Stabilizer Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 18. Transthyretin Stabilizer Consumed in Drug Stores
Figure 19. Global Transthyretin Stabilizer Market: Drug Stores (2018-2023) & (K Units)
Figure 20. Transthyretin Stabilizer Consumed in Online Pharmacies
Figure 21. Global Transthyretin Stabilizer Market: Online Pharmacies (2018-2023) & (K Units)
Figure 22. Transthyretin Stabilizer Consumed in Others
Figure 23. Global Transthyretin Stabilizer Market: Others (2018-2023) & (K Units)
Figure 24. Global Transthyretin Stabilizer Sales Market Share by Application (2022)
Figure 25. Global Transthyretin Stabilizer Revenue Market Share by Application in 2022
Figure 26. Transthyretin Stabilizer Sales Market by Company in 2022 (K Units)
Figure 27. Global Transthyretin Stabilizer Sales Market Share by Company in 2022
Figure 28. Transthyretin Stabilizer Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Transthyretin Stabilizer Revenue Market Share by Company in 2022
Figure 30. Global Transthyretin Stabilizer Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Transthyretin Stabilizer Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 33. Americas Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 34. APAC Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 35. APAC Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 36. Europe Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 37. Europe Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 40. Americas Transthyretin Stabilizer Sales Market Share by Country in 2022
Figure 41. Americas Transthyretin Stabilizer Revenue Market Share by Country in 2022
Figure 42. Americas Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 43. Americas Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 44. United States Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Transthyretin Stabilizer Sales Market Share by Region in 2022
Figure 49. APAC Transthyretin Stabilizer Revenue Market Share by Regions in 2022
Figure 50. APAC Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 51. APAC Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 52. China Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Transthyretin Stabilizer Sales Market Share by Country in 2022
Figure 60. Europe Transthyretin Stabilizer Revenue Market Share by Country in 2022
Figure 61. Europe Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 62. Europe Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 63. Germany Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 72. Egypt Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Transthyretin Stabilizer in 2022
Figure 78. Manufacturing Process Analysis of Transthyretin Stabilizer
Figure 79. Industry Chain Structure of Transthyretin Stabilizer
Figure 80. Channels of Distribution
Figure 81. Global Transthyretin Stabilizer Sales Market Forecast by Region (2024-2029)
Figure 82. Global Transthyretin Stabilizer Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Transthyretin Stabilizer Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Transthyretin Stabilizer Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Transthyretin Stabilizer Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Transthyretin Stabilizer Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Transthyretin Stabilizer
Figure 2. Transthyretin Stabilizer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transthyretin Stabilizer Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Transthyretin Stabilizer Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Transthyretin Stabilizer Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Diflunisal
Figure 10. Product Picture of Tafamidis
Figure 11. Product Picture of Others
Figure 12. Global Transthyretin Stabilizer Sales Market Share by Type in 2022
Figure 13. Global Transthyretin Stabilizer Revenue Market Share by Type (2018-2023)
Figure 14. Transthyretin Stabilizer Consumed in Hospital Pharmacies
Figure 15. Global Transthyretin Stabilizer Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 16. Transthyretin Stabilizer Consumed in Retail Pharmacies
Figure 17. Global Transthyretin Stabilizer Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 18. Transthyretin Stabilizer Consumed in Drug Stores
Figure 19. Global Transthyretin Stabilizer Market: Drug Stores (2018-2023) & (K Units)
Figure 20. Transthyretin Stabilizer Consumed in Online Pharmacies
Figure 21. Global Transthyretin Stabilizer Market: Online Pharmacies (2018-2023) & (K Units)
Figure 22. Transthyretin Stabilizer Consumed in Others
Figure 23. Global Transthyretin Stabilizer Market: Others (2018-2023) & (K Units)
Figure 24. Global Transthyretin Stabilizer Sales Market Share by Application (2022)
Figure 25. Global Transthyretin Stabilizer Revenue Market Share by Application in 2022
Figure 26. Transthyretin Stabilizer Sales Market by Company in 2022 (K Units)
Figure 27. Global Transthyretin Stabilizer Sales Market Share by Company in 2022
Figure 28. Transthyretin Stabilizer Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Transthyretin Stabilizer Revenue Market Share by Company in 2022
Figure 30. Global Transthyretin Stabilizer Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Transthyretin Stabilizer Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 33. Americas Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 34. APAC Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 35. APAC Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 36. Europe Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 37. Europe Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Transthyretin Stabilizer Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Transthyretin Stabilizer Revenue 2018-2023 ($ Millions)
Figure 40. Americas Transthyretin Stabilizer Sales Market Share by Country in 2022
Figure 41. Americas Transthyretin Stabilizer Revenue Market Share by Country in 2022
Figure 42. Americas Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 43. Americas Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 44. United States Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Transthyretin Stabilizer Sales Market Share by Region in 2022
Figure 49. APAC Transthyretin Stabilizer Revenue Market Share by Regions in 2022
Figure 50. APAC Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 51. APAC Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 52. China Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Transthyretin Stabilizer Sales Market Share by Country in 2022
Figure 60. Europe Transthyretin Stabilizer Revenue Market Share by Country in 2022
Figure 61. Europe Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 62. Europe Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 63. Germany Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Transthyretin Stabilizer Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Transthyretin Stabilizer Sales Market Share by Application (2018-2023)
Figure 72. Egypt Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Transthyretin Stabilizer Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Transthyretin Stabilizer in 2022
Figure 78. Manufacturing Process Analysis of Transthyretin Stabilizer
Figure 79. Industry Chain Structure of Transthyretin Stabilizer
Figure 80. Channels of Distribution
Figure 81. Global Transthyretin Stabilizer Sales Market Forecast by Region (2024-2029)
Figure 82. Global Transthyretin Stabilizer Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Transthyretin Stabilizer Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Transthyretin Stabilizer Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Transthyretin Stabilizer Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Transthyretin Stabilizer Revenue Market Share Forecast by Application (2024-2029)
